Çoklu Hepatik ve Ekstrahepatik Hidatik Kistlerde Etil Alkol ile Başarılı Perkütan Tedavi; Uzun Dönem Sonuçlar

SÜLEYMAN BAKDIK , MUHARREM KESKİN , BEKİR TURGUT

  • SÜLEYMAN BAKDIK: Necmettin Erbakan Üniversitesi Tıp Fakültesi
  • MUHARREM KESKİN: NECMETTİN ERBAKAN ÜNİVERSİTESİ
  • Year : 2026
  • Vol : 42
  • Issue : 2
  •  Page : 127-134
Amaç: Kist hidatik, yüksek morbidite ve mortalite oranlarına sahip ve daha uzun hastanede kalış süreleri olan invaziv cerrahi yöntemlerle tedavi edilir. Ancak son yirmi yılda, düşük morbidite ve mortalite oranlarıyla mükemmel sonuçlar sağlayan minimal invaziv perkütan tedaviler geliştirilmiştir. Bu çalışmada, yaygın karaciğer hidatik kistlerinin (HK) perkütan tedavisini ve ayrıca skolisidal ve sklerozan bir ajan olarak alkolün terapötik başarı oranlarını, etkinliğini ve avantajlarını göstermeyi amaçladık. Gereç ve Yöntemler: Eylül 2016 ile Aralık 2018 tarihleri arasında yaygın karaciğer ve karaciğer dışı HK nedeniyle başvuran, 6 cm kistler kateterizasyon (SPC) yöntemi ile tedavi edildi. Tüm HK tip 2 ve tip 3b (Gharbi tip 3) kistleri modifiye kateterizasyon (MoCAT) tekniği ile tedavi edildi. Bulgular: 23 hastadaki 132 lezyonun tamamı (%100) perkütan olarak başarıyla tedavi edildi. 80 kistte (%60,61) psödotümör görünümü, 33 kistte (%25) %50'den fazla hacim küçülmesi, kist duvarında kalınlaşma, kist konturlarında düzensizlik, membran dekolmanı ve 10 kistte (%7,58) kist hacminde %50'den az küçülme ve 9 kistte (%6,82) tamamen kaybolma tespit edildi. Sonuç: Perkütan tedaviler, hepatik ve ekstrahepatik yaygın hidatik kistli hastalarda başarılı sonuçlar sağlayan güvenli ve etkili yöntemlerdir ve cerrahi tedavilerle yüksek morbidite oranları nedeniyle yaygın hastalık için ilk tedavi yöntemi olmalıdır. Güvenli sınırlar ve önlemler sağlandığı takdirde, skolisidal ve sklerozan bir ajan olarak alkol, yaygın hastalıkta güvenli ve etkili görünmektedir. Anahtar Kelimeler: Dissemine hidatik kist, etil alkol enjeksiyonu, ekstrahepatik hidatik kistler, girişimsel radyoloji, perkütan kist tedavisi
Cite this Article As : Bakdik S, Keskin M, Turgut B. Successfully Percutaneous Treatment with Ethyl Alcohol in Multiple Hepatic and Extrahepatic Hydatid Cysts; Long Term Outcomes. Selcuk Med J 2026;42(2): 127-134

Download Citation: Endnote/Zotero/Mendeley (RIS) RIS File

Download Citation: BibTeX BibTeX File

Conflict of interest : The authors declare that they have no conflict of interest.
This article is published under the CC BY-NC 4.0 license.
Selcuk Medical Journal
2026, Vol. 42 (2)
ISSN: 1017-6616
E-ISSN: 2149-8059
Received : , Accepted : , Published Online :

References

  1. 1. Pakala T, Molina M, Wu GY. Hepatic Echinococcal Cysts: A Review. J Clin Transl Hepatol. 2016;4(1):39-46. doi:10.14218/JCTH.2015.00036
  2. 2. Lianos GD, Lazaros A, Vlachos K, et al. Unusual locations of hydatid disease: a 33 year's experience analysis on 233 patients. Updates Surg. 2015;67(3):279-82. doi:10.1007/s13304-015-0291-6
  3. 3. Giorgio A, de Stefano G, Di Sarno A, et al. Clinical and sonographic management of viable hydatid liver cysts. J Ultrasound. 2008;11(3):107-12. doi:10.1016/j.jus.2008.05.004
  4. 4. Sozuer E, Akyuz M, Akbulut S. Open surgery for hepatic hydatid disease. Int Surg. 2014;99(6):764-69. doi:10.9738/INTSURG-D-14-00069.1
  5. 5. Fisichella PM, Donaldson K, Helton WS. Hepatic and splenic hydatidosis managed with percutaneous aspiration, injection, and reaspiration (PAIR) of the hepatic cyst and laparoscopic splenectomy. J Gastrointest Surg. 2008;12(9):1615-17. doi:10.1007/s11605-007-0419-1
  6. 6. Paksoy Y, Odev K, Sahin M, et al. Percutaneous treatment of liver hydatid cysts: comparison of direct injection of albendazole and hypertonic saline solution. AJR Am J Roentgenol. 2005;185(3):727-34. doi:10.2214/ajr.185.3.01850727
  7. 7. Akhan O, Yildiz AE, Akinci D, et al. Is the adjuvant albendazole treatment really needed with PAIR in the management of liver hydatid cysts? A prospective, randomized trial with short-term follow-up results. Cardiovasc Intervent Radiol. 2014;37(6):1568-74. doi:10.1007/s00270-014-0840-2
  8. 8. Akhan O, Ozmen MN. Percutaneous treatment of liver hydatid cysts. Eur J Radiol. 1999;32(1):76-85. doi:10.1016/s0720-048x(99)00116-3
  9. 9. Giorgio A, de Stefano G, Esposito V, et al. Long-term results of percutaneous treatment of hydatid liver cysts: a single center 17 years experience. Infection. 2008;36(3):256-61. doi:10.1007/s15010-007-7103-y
  10. 10. Kahriman G, Ozcan N, Donmez H. Hydatid cysts of the liver in children: percutaneous treatment with ultrasound follow-up. Pediatr Radiol. 2011;41(7):890-94. doi:10.1007/s00247-011-2088-1
  11. 11. Nayman A, Guler I, Keskin S, et al. A novel modified PAIR technique using a trocar catheter for percutaneous treatment of liver hydatid cysts: a six-year experience. Diagn Interv Radiol. 2016;22(1):47-51. doi:10.5152/dir.2015.15011
  12. 12. Arslan S, Bakdik S, Oncu F, et al. Successful percutaneous treatment of extrahepatic cystic echinococcosis through PAIR and single puncture catheter techniques. Jpn J Radiol. 2017;35(6):296-02. doi:10.1007/s11604-017-0633-z
  13. 13. Kabaalioğlu A, Ceken K, Alimoglu E, et al. Percutaneous imaging-guided treatment of hydatid liver cysts: do long-term results make it a first choice?. Eur J Radiol. 2006;59(1):65-73. doi:10.1016/j.ejrad.2006.01.014
  14. 14. Velasco-Tirado V, Alonso-Sardón M, Lopez-Bernus A, et al. Medical treatment of cystic echinococcosis: systematic review and meta-analysis. BMC Infect Dis. 2018 Jul 5;18(1):306. doi: 10.1186/s12879-018-3201-y.
  15. 15 Mohamed AE, Yasawy MI, Al Karawi MA. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. Hepatogastroenterology. 1998 Sep-Oct;45(23):1690-94. PMID: 9840130.
  16. 16. Cobo F, Yarnoz C, Sesma B, et al. Albendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intra-abdominal hydatisosis caused by Echinococcus granulosus. Trop Med Int Health. 1998;3(6):462-66. doi:10.1046/j.1365-3156.1998.00257.x
  17. 17. Anand S, Rajagopalan S, Mohan R. Retraction notice to "Management of liver hydatid cysts - Current perspectives" Med J Armed Forces India. 2017;73(1):104. doi:10.1016/j.mjafi.2016.12.011
  18. 18. Gomez I Gavara C, López-Andújar R, Belda Ibáñez T, et al. Review of the treatment of liver hydatid cysts. World J Gastroenterol. 2015;21(1):124-31. doi:10.3748/wjg.v21.i1.124
  19. 19. Gharbi HA, Hassine W, Brauner MW, et al. Ultrasound examination of the hydatic liver. Radiology. 1981;139(2):459-63. doi:10.1148/radiology.139.2.7220891
  20. 20. WHO Informal Working Group. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop. 2003;85(2):253-61. doi:10.1016/s0001-706x(02)00223-1
  21. 21. Giorgio A, Di Sarno A, de Stefano G, et al. Sonography and clinical outcome of viable hydatid liver cysts treated with double percutaneous aspiration and ethanol injection as first-line therapy: efficacy and long-term follow-up. AJR Am J Roentgenol. 2009;193(3): W186-W192. doi:10.2214/AJR.08.1518
  22. 22. Tüzün M, Hekimoğlu B. Pictorial essay. Various locations of cystic and alveolar hydatid disease: CT appearances. J Comput Assist Tomogr. 2001;25(1):81-87. doi:10.1097/00004728-200101000-00014
  23. 23. Stojkovic M, Rosenberger K, Kauczor HU, et al. Diagnosing and staging of cystic echinococcosis: how do CT and MRI perform in comparison to ultrasound? PLoS Negl Trop Dis. 2012;6(10):e1880. doi:10.1371/journal.pntd.0001880
  24. 24. Marani SA, Canossi GC, Nicoli FA, et al. Hydatid disease: MR imaging study. Radiology. 1990;175(3):701-06. doi:10.1148/radiology.175.3.2343117
  25. 25. Gupta N, Javed A, Puri S, et al. Hepatic hydatid: PAIR, drain or resect? J Gastrointest Surg. 2011;15(10):1829-36. doi:10.1007/s11605-011-1649-9
  26. 26. Citgez B, Battal M, Cipe G, et al. Feasibility and safety of laparoscopic hydatid surgery: a systematic review. Hepatogastroenterology. 2013;60(124):784-88. doi:10.5754/hge12527
  27. 27. Yagci G, Ustunsoz B, Kaymakcioglu N, et al. Results of surgical, laparoscopic, and percutaneous treatment for hydatid disease of the liver: 10 years experience with 355 patients. World J Surg. 2005;29(12):1670-79. doi:10.1007/s00268-005-0058-1
  28. 28. Castellano G, Moreno-Sanchez D, Gutierrez J, et al. Caustic sclerosing cholangitis. Report of four cases and a cumulative review of the literature. Hepatogastroenterology. 1994;41(5):458-70.
  29. 29. Filice C, Pirola F, Brunetti E, et al. A new therapeutic approach for hydatid liver cysts. Aspiration and alcohol injection under sonographic guidance. Gastroenterology. 1990;98(5 Pt 1):1366-68. doi:10.1016/0016-5085(90)90358-8
  30. 30. Bakdik S, Arslan S, Oncu F, et al. Percutaneous treatment of hepatic cystic echinococcosis: the success of alcohol as a single endocavitary agent in PAIR, catheterization, and modified catheterization techniques. Radiol Med. 2018;123(2):153-60. doi:10.1007/s11547-017-0820-0
  31. 31. Jang SY, Park SY, Tak WY, et al. Long-term follow-up of large symptomatic hepatic cysts treated by percutaneous ethanol sclerotherapy. Acta Radiol. 2016;57(10):1205-09. doi:10.1177/0284185115626476
  32. 32. Cheng D, Amin P, Ha TV. Percutaneous sclerotherapy of cystic lesions. Semin Intervent Radiol. 2012;29(4):295-00. doi:10.1055/s-0032-1330063
  33. 33. Sönmez K, Karabulut R, Türkyilmaz Z, et al. Clear cystic fluid in hepatic hydatidosis does not rule out communication between cysts and the biliary system. Adv Ther. 2007;24(2):291-95. doi:10.1007/BF02849896
  34. 34. Siracusano A, Teggi A, Ortona E. Human cystic echinococcosis: old problems and new perspectives. Interdiscip Perspect Infect Dis. 2009;2009:474368. doi:10.1155/2009/474368
  35. 35. Corona M, Cannavale A, Bruni A, et al. Case report: Percutaneous treatment of multiple honeycomb-like liver hydatid cysts (type III CE2, according to WHO classification). Indian J Radiol Imaging. 2012;22(1):23-26. doi:10.4103/0971-3026.95399
Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3